BBS-Bioactive Bone Substitutes PLC

OHEL:BONEH (Finland)   Ordinary Shares
€ 0.10 (+0.62%) Nov 29
At Loss
P/B:
0.54
Market Cap:
€ 2.48M ($ 2.63M)
Enterprise V:
€ 7.21M ($ 7.63M)
Volume:
112.14K
Avg Vol (2M):
112.12K
Trade In:

Business Description

BBS-Bioactive Bone Substitutes PLC

ISIN : FI4000260583

Share Class Description:

OHEL:BONEH: Ordinary Shares
Description
BBS-Bioactive Bone Substitutes PLC) is a biomedical technology company that develops, manufactures, and commercializes innovative, bioactive medical devices and implants for orthopaedic surgery, and develops, designs, and manufactures bioactive bone-graft substitute implants. Its ortho-biological product ARTEBONE, which is based on tricalcium phosphate and a natural spectrum of bone proteins has the capability of bone regeneration.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.15
Equity-to-Asset 0.41
Debt-to-Equity 1.47
Debt-to-EBITDA -1.76
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 59.48
9-Day RSI 37.66
14-Day RSI 30.91
6-1 Month Momentum % -21.93
12-1 Month Momentum % -36.15

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.39
Quick Ratio 0.39
Cash Ratio 0.37
Days Payable 3501.72

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -31.9
Shareholder Yield % -54.25

Profitability Rank

Name Current Vs Industry Vs History
ROE % -80.47
ROA % -34.74
ROIC % -32.42
ROC (Joel Greenblatt) % -328.32
ROCE % -40.79
Years of Profitability over Past 10-Year 1

GF Value Rank

Name Current Vs Industry Vs History
PB Ratio 0.54
EV-to-EBIT -2.13
EV-to-EBITDA -2.28
EV-to-FCF -2.35
Earnings Yield (Greenblatt) % -46.95
FCF Yield % -123.61

Financials (Next Earnings Date:2025-02-26 Est.)

OHEL:BONEH's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

BBS-Bioactive Bone Substitutes PLC Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €)
EPS (TTM) (€) -0.179
Beta 0.83
Volatility % 68.38
14-Day RSI 30.91
14-Day ATR (€) 0.018665
20-Day SMA (€) 0.108625
12-1 Month Momentum % -36.15
52-Week Range (€) 0.05 - 0.642481
Shares Outstanding (Mil) 25.48

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

BBS-Bioactive Bone Substitutes PLC Filings

Filing Date Document Date Form
No Filing Data

BBS-Bioactive Bone Substitutes PLC Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

BBS-Bioactive Bone Substitutes PLC Frequently Asked Questions

What is BBS-Bioactive Bone Substitutes PLC(OHEL:BONEH)'s stock price today?
The current price of OHEL:BONEH is €0.10. The 52 week high of OHEL:BONEH is €0.64 and 52 week low is €0.05.
When is next earnings date of BBS-Bioactive Bone Substitutes PLC(OHEL:BONEH)?
The next earnings date of BBS-Bioactive Bone Substitutes PLC(OHEL:BONEH) is 2025-02-26 Est..
Does BBS-Bioactive Bone Substitutes PLC(OHEL:BONEH) pay dividends? If so, how much?
BBS-Bioactive Bone Substitutes PLC(OHEL:BONEH) does not pay dividend.

Press Release

Subject Date
No Press Release